CORRECTION article

Front. Oncol., 08 September 2025

Sec. Cancer Immunity and Immunotherapy

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1641399

Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K/AKT/NF-κB-signaling pathway to inhibit the polarization of M2 TAMs

  • 1. Department of Obstetrics & Gynecology, The Second Affiliated Hospital of Nanchang University, Nanchang, China

  • 2. Department of Obstetrics & Gynecology, The First Affiliated Hospital of Nanchang University, Nanchang, China

  • 3. Institute of Translational Medicine, Nanchang University, Nanchang, China

There was a mistake in Figure 3 as published. In Figure 3C, there are instances of duplicated areas between some images due to carelessness. Specifically, these occur between: Migration-C and Invasion-Co-C; Invasion-C and Migration-12.5nM TPL; Invasion-C and Invasion-6.25nM TPL; Invasion-Co-C and Invasion-12.5nM TPL; Invasion-6.25nM TPL and Migration-25nM TPL; Invasion-6.25nM TPL and Migration-12.5nM TPL. The corrected Figure 3 appears below.

Figure 3

The original version of this article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

A2780/DDP cells, cisplatin (DDP) resistance, triptolide (TPL), PI3K/AKT/NF-κB- pathway, tumor-associated macrophages (TAMs)

Citation

Le F, Yang L, Han Y, Zhong Y, Zhan F, Feng Y, Hu H, Chen T and Tan B (2025) Correction: TPL inhibits the invasion and migration of drug-resistant ovarian cancer by targeting the PI3K/AKT/NF-κB-signaling pathway to inhibit the polarization of M2 TAMs. Front. Oncol. 15:1641399. doi: 10.3389/fonc.2025.1641399

Received

05 June 2025

Accepted

20 August 2025

Published

08 September 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2025

Updates

Copyright

*Correspondence: Tingtao Chen, ; Buzhen Tan, ; Hui Hu,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics